• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Israel·Financial Services·MCMN.TA
Share

Blackedge Ltd Stocks

ILA 31700Last Updated 08.12.2025

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

ILA 1.90M

ILA 31700
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Blackedge Ltd offers a range of financial services to businesses operating within Israel. The company provides capital to residential real estate developers, typically requiring real estate as security, which may involve pledges on assets or project surpluses. It also extends credit secured by pledged securities. Furthermore, Blackedge Ltd accepts other forms of collateral, such as vehicles, personal and owner guarantees, assurances from third parties, and current asset pledges. The firm also facilitates credit arrangements that feature deferred repayment terms for the recipient. Established in 2015, Blackedge Ltd is based in Bnei Brak, Israel, and was previously known as Michman Finance Ltd before adopting its current name in November 2025.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 00:34

A War Between the U.S. and Iran Could Drag On for Several Months — Bloomberg

30.07.2026 00:08

Google has disbanded its Nobel Prize-winning team. Some of its members will join Anthropic

29.07.2026 23:01

The Fed has kept interest rates unchanged for the fifth consecutive time. What's next?

29.07.2026 22:23

"It's a Matter of Lost Trust": Chipmakers Lost More Than $1 Trillion in Market Capitalization in Two Days

29.07.2026 22:06

Novo Will Sue Investors Over the Results of a Study on a Weight-Loss Drug

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026